Skip to main content
Log in

Marginal donors: can older donor hearts tolerate prolonged cold ischemic storage?

  • Short Communication
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background and aims

Both advanced donor age and prolonged ischemic time are significant risk factors for the 1-year mortality. However, its functional consequences have not been fully evaluated in the early-phase after transplantation; even early graft dysfunction is the main determinant of long-term outcome following transplantation. We evaluated in vivo left-ventricular (LV) cardiac and coronary vascular function of old-donor grafts after short and prolonged cold ischemic times in rats 1 h after heart transplantation.

Methods

The hearts were excised from young donor (3-month-old) or old donor (18-month-old) rats, stored in cold preservation solution for either 1 or 8 h, and heterotopically transplanted.

Results

After 1 h of ischemic period, in the old-donor group, LV pressure, maximum pressure development (dP/dt max), time constant of LV pressure decay (τ), LV end-diastolic pressure and coronary blood flow did not differ compared with young donors. However, endothelium-dependent vasodilatation to acetylcholine resulted in a significantly lower response of coronary blood flow in the old-donor group (33 ± 4 vs. 51 ± 15 %, p < 0.05). After 8 h preservation, two of the old-donor hearts showed no mechanical activity upon reperfusion. LV pressure (55 ± 6 vs. 72 ± 5 mmHg, p < 0.05), dP/dt max (899 ± 221 vs. 1530 ± 217 mmHg/s, p < 0.05), coronary blood flow and response to acetylcholine were significantly reduced and τ was increased in the old-donor group in comparison to young controls.

Conclusions

During the early-phase after transplantation, the ischemic tolerance of older-donor hearts is reduced after prolonged preservation time and the endothelium is more vulnerable to ischemia/reperfusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Radovits T, Gero D, Lin LN et al (2008) Improvement of aging-associated cardiovascular dysfunction by the orally administered copper(II)-aspirinate complex. Rejuvenation Res 11:945–956

    Article  PubMed  CAS  Google Scholar 

  2. Stehlik J, Edwards LB, Kucheryavaya AY et al (2010) The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report–2010. J Heart Lung Transpl 29:1089–1103

    Article  Google Scholar 

  3. Marasco SF, Esmore DS, Negri J et al (2005) Early institution of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transpl 24:2037–2042

    Article  Google Scholar 

  4. Szabo G, Bahrle S, Stumpf N et al (2002) Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 90:100–106

    Article  PubMed  CAS  Google Scholar 

  5. McCrystal GD, Pepe S, Esmore DS et al (2004) The challenge of improving donor heart preservation. Heart Lung Circ 13:74–83

    Article  PubMed  Google Scholar 

  6. Csiszar A, Ungvari Z, Edwards JG et al (2002) Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 90:1159–1166

    Article  PubMed  CAS  Google Scholar 

  7. van der Loo B, Labugger R, Skepper JN et al (2000) Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med 192:1731–1744

    Article  PubMed  Google Scholar 

  8. Kur F, Beiras-Fernandez A, Meiser B et al (2009) Clinical heart transplantation with extended preservation time (>5 h): experience with University of Wisconsin solution. Transpl Proc 41:2247–2249

    Article  CAS  Google Scholar 

  9. Appleyard RF, Cohn LH (1993) Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg 8:316–324

    PubMed  CAS  Google Scholar 

  10. Radovits T, Seres L, Gero D et al (2007) Single dose treatment with PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular dysfunction. Exp Gerontol 42:676–685

    Article  PubMed  CAS  Google Scholar 

  11. Radovits T, Seres L, Gero D et al (2007) The peroxynitrite decomposition catalyst FP15 improves ageing-associated cardiac and vascular dysfunction. Mech Ageing Dev 128:173–181

    Article  PubMed  CAS  Google Scholar 

  12. Szabo G, Loganathan S, Merkely B et al (2012) Catalytic peroxynitrite decomposition improves reperfusion injury after heart transplantation. J Thorac Cardiovasc Surg 143:1443–1449

    Article  PubMed  CAS  Google Scholar 

  13. Oriyanhan W, Yamazaki K, Miwa S et al (2005) Taurine prevents myocardial ischemia/reperfusion-induced oxidative stress and apoptosis in prolonged hypothermic rat heart preservation. Heart Vessels 20:278–285

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sevil Korkmaz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korkmaz, S., Bährle-Szabó, S., Loganathan, S. et al. Marginal donors: can older donor hearts tolerate prolonged cold ischemic storage?. Aging Clin Exp Res 25, 597–600 (2013). https://doi.org/10.1007/s40520-013-0131-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-013-0131-9

Keywords

Navigation